Navarro G y cols. Insulinoma recidivado durante el embarazo. Rev Argent Cir. 2026;118(1):e-1896
3
La paciente es externada sin posteriores com- mujeres embarazadas no solo se ven reflejados en
plicaciones, con un seguimiento mulꢀdisciplinario. A el posoperatorio, sino también en la seguridad para
los cuatro meses de la realización de la cirugía se en- el feto.
cuentra cursando su embarazo sin complicaciones.
En el caso de pacientes que cursan un embara-
La resolución quirúrgica de los insulinomas es zo se sugiere realizar la cirugía en el segundo trimestre,
un tema de debate. En caso de tumores pequeños y entre las semanas 12 y 17, aunque se encuentran casos
bien localizados, la enucleación pareciera ser la indica- descriptos del manejo quirúrgico en el primer trimestre
4
-6
ción, mientras que las resecciones pancreáꢀcas podrían y en el momento de la cesárea .
uꢀlizarse en casos de afectación del conducto pancreá- El seguimiento a largo plazo de los pacientes,
co principal, sospecha de malignidad o la presencia de sobre todo en el caso de enucleaciones, debe ser es-
ꢀ
5
adenomegalias .
tricto. Si bien la tasa de recurrencia de estos tumores
En el caso aquí presentado, la resolución la- es muy baja, de 5 a 7% a los 20 años, en este caso se
paroscópica del insulinoma, antes y durante el emba- describe una recidiva a los 15 meses posterior a una
razo, demostró ser una alternaꢀva terapéuꢀca segura enucleación laparoscópica. Es importante resaltar que
con la resolución de los síntomas. Los beneficios de no existen casos informados de recurrencia durante el
4
realizar el procedimiento laparoscópico en el caso de embarazo .
■
ENGLISH VERSION
Pancreaꢀc insulinomas are rare, usually small,
The aim of this publicaꢀon was to describe the
and benign neuroendocrine tumors. Insulin secreꢀon case of a paꢀent diagnosed with an insulinoma, the
becomes unregulated, leading to low blood glucose subsequent surgical management, and the recurrence
levels and spontaneous hypoglycemia, parꢀcularly aꢂer of the condiꢀon during pregnancy.
meals. The incidence of insulinomas ranges from 1 to 4
A 24-year-old otherwise healthy female
cases per million populaꢀon per year. Of these cases, paꢀent presented with seizures to the emergency
9
9
5% are sporadic, and 60% are observed in women. In department, where a diagnosis of hypoglycemia was
0% of cases, insulinomas occur in the pancreas, while made with blood glucose levels of 14 mg/dL. The
1
only 10% are extra-pancreaꢀc .
paꢀent reported neuroglycopenic symptoms, including
Insulinomas rarely develop in pregnant weakness, dizziness, and lethargy, every day for six
paꢀents and are therefore difficult to diagnose. Few months. She was admiꢃed to the intensive care unit
cases have been reported in the literature. Severe with orotracheal intubaꢀon due to poor performance
hypoglycemia in non-diabeꢀc pregnant paꢀents is a status. Because adrenal insufficiency was suspected,
rare occurrence, and, when present, insulinoma is a treatment with corꢀcosteroids was iniꢀated, which led
suspected diagnosis. Whipple’s triad, characterized by to improvement in the clinical picture.
symptoms of hypoglycemia, hypoglycemia documented
Laboratory tests show blood glucose levels of
in laboratory tests and recovery of symptoms aꢂer 20 mg/dL, insulin levels of 18.8 μU/mL, insulin/glucose
glucose administraꢀon, can serve as a guide to raꢀo of 0.94, and C-pepꢀde levels of 2.7 ng/mL.
diagnosis. The diagnosis is made by measuring blood
A CT scan with an intravenous (IV) contrast
insulin and glucose levels, which is the gold standard agent (Fig. 1) revealed a nodular image with lobulated
procedure. Insulin levels greater than 6 μU/mL, borders at the anterior edge of the tail of the pancreas.
combined with glucose levels less than or equal to 45 The nodule measured 25 mm in diameter and exhibited
mg/dL, and a C-pepꢀde level greater than or equal to hyperenhancement in the arterial phase. The rest of
0
.2 nmol/L, along with a negaꢀve sulfonylurea test and the pancreas appeared normal. The main pancreaꢀc
negaꢀve anꢀ-insulin anꢀbodies, indicate the presence duct was preserved.
2
of an insulinoma . The selecꢀon of diagnosꢀc imaging
The insulinoma was enucleated through
tests to ascertain the precise locaꢀon of the tumor laparoscopic surgery, without complicaꢀons (Fig. 2A).
depends on their availability. The preferred methods The paꢀent experienced clinical improvement in the
are computed tomography (CT) with a sensiꢀvity of immediate postoperaꢀve period and was discharged
7
8
5-100% and magneꢀc resonance imaging (MRI) with on postoperaꢀve day 4. During follow-up, she remained
5% sensiꢀvity. Endoscopic ultrasound has recently asymptomaꢀc and the laboratory tests were normal.
emerged as the preferred diagnosꢀc method for this
Pathological examinaꢀon revealed a well-
3
disease, owing to its sensiꢀvity and specificity .
differenꢀated (G1) pancreaꢀc neuroendocrine tumor,
The recurrence of insulinomas during with a mitoꢀc count of <2 mitoses per 10 HPF, no
pregnancy is extremely rare, with only a few cases evidence of vascular or perineural invasion or necrosis,
reported .
4
and immunohistochemical posiꢀvity for synaptophysin,